Related references
Note: Only part of the references are listed.Well-Defined Multivalent Ligands for Hepatocytes Targeting via Asialoglycoprotein Receptor
Xiangang Huang et al.
BIOCONJUGATE CHEMISTRY (2017)
An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria
Abigail Liebow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
siRNA carrying an (E)-vinylphosphonate moiety at the 5′ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2
Elad Elkayam et al.
NUCLEIC ACIDS RESEARCH (2017)
Clinical Proof of Concept for a Novel Hepatocyte-Targeting GaINAc-siRNA Conjugate
Tracy S. Zimmermann et al.
MOLECULAR THERAPY (2017)
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
Kevin Fitzgerald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Synergistic effect of phosphorothioate, 5′-vinylphosphonate and GalNAc modifications for enhancing activity of synthetic siRNA
Thazha P. Prakash et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
A convenient synthesis of 5′-triantennary N-acetyl-galactosamine clusters based on nitromethanetrispropionic acid
Michael T. Migawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
9 5′-(E)-Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA-GalNAc Conjugates
Rubina Parmar et al.
CHEMBIOCHEM (2016)
Comprehensive Structure-Activity Relationship of Triantennary N-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to Hepatocytes
Thazha P. Prakash et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys
Rosie Z. Yu et al.
NUCLEIC ACID THERAPEUTICS (2016)
Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice
Rosie Z. Yu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
Shigeo Matsuda et al.
ACS CHEMICAL BIOLOGY (2015)
Hepatocyte-Specific Delivery of siRNAs Conjugated to Novel Non-nucleosidic Trivalent N-Acetylgalactosamine Elicits Robust Gene Silencing in Vivo
Kallanthottathil G. Rajeev et al.
CHEMBIOCHEM (2015)
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia
Alfica Sehgal et al.
NATURE MEDICINE (2015)
Knocking down disease: a progress report on siRNA therapeutics
Anders Wittrup et al.
NATURE REVIEWS GENETICS (2015)
Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification
Amy Chan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
Jayaprakash K. Nair et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2014)
Reactivity of 3H-1,2,4-dithiazole-3-thiones and 3H-1,2-dithiole-3-thiones as sulfurizing agents for oligonucleotide synthesis
Andrei P. Guzaev
TETRAHEDRON LETTERS (2011)
Quantitative evaluation of siRNA delivery in vivo
Yi Pei et al.
RNA (2010)
Synthesis and characterization of 2-modified-4-thioRNA: a comprehensive comparison of nuclease stability
Mayumi Takahashi et al.
NUCLEIC ACIDS RESEARCH (2009)
Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA
CR Allerson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
In vivo activity of nuclease-resistant siRNAs
JM Layzer et al.
RNA (2004)
Current strategies for the synthesis of RNA
S Müller et al.
CURRENT ORGANIC SYNTHESIS (2004)
Design and synthesis of novel N-acetylgalactosamine-terminated glycolipids for targeting of lipoproteins to the hepatic asialoglycoprotein receptor
PCN Rensen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo
PCN Rensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
